Loomis Optical | |
4300 West Layton Avenue, Ste 100, Greenfield, WI 53220-5132 | |
(414) 928-2020 | |
(414) 210-3402 |
Full Name | Loomis Optical |
---|---|
Type | Facility |
Speciality | Ophthalmology |
Location | 4300 West Layton Avenue, Greenfield, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174217178 | NPI | - | NPPES |
32306500 | Medicaid | WI | |
32735700 | Medicaid | WI | |
0264580001 | Other | WI | DME |
34249800 | Medicaid | WI | |
34678800 | Medicaid | WI | |
38616200 | Medicaid | WI | |
38622400 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Secondary |
207W00000X | Ophthalmology | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Loomis Optical 4300 W. Layton Ave, Ste 100, Greenfield, WI 53220-4136 Ph: (414) 260-0789 | Loomis Optical 4300 West Layton Avenue, Ste 100, Greenfield, WI 53220-5132 Ph: (414) 928-2020 |
News Archive
The Research Training Group, which builds on translational research training programmes and research structures such as the Molecular Medicine degree programme and the Interdisciplinary Centre for Clinical Research, will work on areas where basic research and clinical practice overlap. It will bring together 20 doctoral candidates from the natural sciences and 28 from medicine.
"Over the past three years, malaria passed from first to third cause of infant mortality in Africa, Awa Coll-Seck, executive director of the Roll Back Malaria Partnership [RBM], said Tuesday in Paris," Afrique en ligne reports.
A new study at Rush University Medical Center aims to determine whether a combination of lifestyle changes can protect memory and thinking skills in people at risk of developing dementia.
Genomic Health, Inc. today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued its final local coverage determination (LCD) approving coverage of the Oncotype DX prostate cancer test for qualified Medicare patients throughout the United States.
› Verified 6 days ago